Viracta Therapeutics Inc. (VIRX)
0.02
-0.00 (-6.54%)
At close: Apr 04, 2025, 3:28 PM
13F Institute Ownership
Total Institutes of 32 in Viracta Therapeutics reduced their positions with a decrease of 5 investors compared to the previous quarter. A reduction of 1.99M shares, as total invested capital declined by $711.03K with ownership percentage dropping from 14.12% to 9.10%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 4.11% | 1.63M | +6.97% | 261.67K | < 0.01% |
| Vanguard Group Inc | 0.73% | 289.17K | -69.7% | 46.56K | < 0.01% |
| Aisling Capital Management LP | 0.73% | 288.57K | +0.00% | 46.17K | 0.02% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.